Filing Flows › Rockwell Medical (RMTI) › Guidance & outlook
Rockwell Medical (RMTI) guidance and outlook
Rockwell Medical (RMTI) withdrew its guidance on Nov 3, 2026: Revenue $400M–$450M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $400M–$450M | raised |
From the earnings release filed Nov 3, 2026 (8-K on EDGAR).
Rockwell Medical's latest quarter
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
Questions
Did Rockwell Medical raise or lower its guidance?
Rockwell Medical (RMTI) withdrew its guidance on Nov 3, 2026: Revenue $400M–$450M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.